DAB2IP and gastric cancer: In view of the important role of EMT in tumor metastasis during tumor progression [19, 20], we explored the effect of DAB2IP on EMT progress and revealed that DAB2IP can modulate the expression of EMT marker E-cadherin and vimentin in AGS and SGC7901 gastric cancer cells.